EntryPoint Capital »

Monte Rosa Therapeutics shares owned by EntryPoint Capital

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by EntryPoint Capital from 13F filings

Historical chart of EntryPoint Capital investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by EntryPoint Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $176k 33k 5.30